|Articles|November 19, 2010

Treat to Target: Rheumatoid Arthritis Management in a Value-Based Healthcare System [CME/CPE]
Volume 16
Issue 9 Suppl

Treat to Target: Rheumatoid Arthritis Management in a Value-Based Healthcare System

Download PDF: Treat to Target: Rheumatoid Arthritis Management in a Value-Based Healthcare System

Articles in this issue

almost 16 years ago

Article

The Managed Care Perspective

almost 16 years ago

Article

The Primary Care Perspective

almost 16 years ago

Article

Participating Faculty

almost 16 years ago

Article

Preventing the Progression From Undifferentiated Arthritis to Rheumatoid Arthritis: The Clinical and Economic Implications

almost 16 years ago

Article

Aggressive Treatment of Early Rheumatoid Arthritis: Recognizing the Window of Opportunity and Treating to Target Goals

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Woman getting her eyes checked | Image credit: N F/peopleimages.com - stock.adobe.com

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

ByStella Ko, PharmD, MS,David Tabano, PhD,Mona Kilany, PhD,Kimberly Jinnett, PhD, MSPH,Victor Kirksey, PhD,Reg Ledesma, MS,Sarah Mossburg, PhD,Charlene Nguyen, MPP, BSc,Bryan A. Wilson, PhD, MBA

September 15th 2026

Doctor talking with patient | Image credit: Prostock-studio - stock.adobe.com

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

ByAayush Sisodia, MSHI, BDS

September 15th 2026

Man with chest pain | Image credit: Liubomir - stock.adobe.com

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

ByHector P. Rodriguez, PhD, MPH, Hattie R. Hanley, MPP,Stephen M. Shortell, PhD, MBA, MPH

September 15th 2026

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Treat to Target: Rheumatoid Arthritis Management in a Value-Based Healthcare System

Articles in this issue

Related Content

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

Early Signs of Success for Missouri’s New Notification of Pregnancy

Predicting GLP-1 Discontinuation From Pharmacy Claims

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD

5 Things to Know About the 2026 ESC Heart Failure Guidelines

Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials

FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care